Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Detectify Teams up with Hackers for Change to Benefit Security and Ethical Hacking Communities, Bolster Security for Non-profit Organizations

Partnership provides tools for nonprofits to strengthen security posture, empowers Hackers for Change to train Canada's next generation of cyber security professionalsSTOCKHOLM — Aug. 18, 2021 — Detectify , the SaaS security company powered by ethical hackers, today announced its partnership with Hackers for Change . The collaboration will equip non-profit organizations with the tools required to strengthen security and decrease the likelihood of cyber-attacks, supporting the mission of Hackers for Change to provide charities and

Observe Medical ASA : Invitation to second quarter and first half year 2021 presentation

Observe Medical ASA invites you to a presentation of the second quarter and first half year 2021. The presentation will take place at Felix Konferansesenter in Oslo on Friday, August 20th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com - Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_3/   Representatives from the Company will be: CEO Björn Larsson and CFO Per Arne Nygård. Shortly after the presentation the webcast recording will be published on the same site.   For

Invitation to presentation of Embellence Group’s interim report for the second quarter 2021

Embellence Group publishes the quarterly report for the second quarter (April to June) on August 23 at 08:00 CEST. In connection with the announcement, Embellence Group invites to a video conference on the same day, held at 10:00 CEST.The presentation will be held in English by Olle Svensk (CEO) and Pär Ihrskog (CFO). To attend, use the link https://tv.streamfabriken.com/embellence-group-q2-2021 or dial in at +443333009266 (UK) or +46856642695 (Sweden). Subscribe to reports and press releases:https://www.embellencegroup.com/newsroom/subscribe/

Introducing BICO: The Global Leader in the Bio Convergence Revolution

CELLINK Life Sciences has transformed itself to create a more growth-oriented business structure for faster life science innovations. To better reflect the new structure and all the opportunities that lies within, the Group has changed name to BICO (BIo COnvergence) while maintaining the CELLINK name for the bioprinting business. BICO, a leader in the life sciences space, has announced its transition from CELLINK to concentrate on the intersection of biology and technology. Since its founding in 2016, BICO has built one of the world’s most expansive portfolio of life science

Netigate recruits former Klarna executive Erik Nordqvist as new CFO

Netigate, one of Europe’s leading providers of feedback management, has recruited Erik Nordqvist  as its new Chief Financial Officer (CFO).Erik has extensive experience in rapidly growing international companies and was most recently Head of Group Business Control at tech giant Klarna, where he was responsible for budget management and financial analysis. He has a background in consulting, including working for Ernst & Young, where he gained valuable experience in

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release August 18, 2021 at 2:45 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on August 18, 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds reached the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on August 17, 2021. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+---------------

Correction: Polymer Factory Sweden AB signs OEM agreement with Bruker Daltonics GmbH and Co. KG

Correction of the previously disclosed press release since the information is regarded as insider information. The MAR-label has therefore been added to the press release.Polymer Factory today announces the entering of an OEM agreement with Bruker Daltonics GmbH and Co. KG the global supplier of the MALDI Biotyper microbial identification system. Polymer Factory will provide products from its SpheriCal® platform for use as internal MALDI MS standards in the analysis of antimicrobial resistance.  As of 18 August 2021, Polymer Factory has entered an OEM relationship with Bruker regarding

Polymer Factory Sweden AB signs OEM agreement with Bruker Daltonics GmbH and Co. KG

Polymer Factory today announces the entering of an OEM agreement with Bruker Daltonics GmbH and Co. KG the global supplier of the MALDI Biotyper microbial identification system. Polymer Factory will provide products from its SpheriCal® platform for use as internal MALDI MS standards in the analysis of antimicrobial resistance.As of 18 August 2021, Polymer Factory has entered an OEM relationship with Bruker regarding products from the company’s SpheriCal® MALDI MS calibrant platform. The supply of the SpheriCal® products will enable Bruker to provide state-of-the-art solutions for use in

Invitation to Presentation of Second Quarter 2021 Results

Solstad Offshore ASA (“Solstad”) welcomes to presentation of its 2Q 2021 report, Wednesday August 25[th], 2021 at 09:00 am. The presentation will be held by Lars Peder Solstad and Kjetil Ramstad. Solstad will publish its 2Q 2021 report Tuesday August 24th. Solstad Offshore 2Q 2021 presentation:Date: Wednesday, August 25[th], 2021  Time: 09:00 a.m. CESTFormat: Live webcastLanguage: EnglishLink: https://channel.royalcast.com/landingpage/hegnarmedia/20210825_9/ The 2[nd] quarter 2021 report and presentation will be made available at www.solstad.com and https://live.euronext.

ExpreS2ion management will present the Q2 2021 interim report via webcast on Thursday, August 19, 2021

ExpreS2ion Biotech Holding AB (“ExpreS2ion") will present its second quarter 2021 report via a live virtual webcast hosted by HC Andersen Capital on August 19[th], 2021, at 11-11.30hrs.Meet and ask questions directly to our CEO, Bent U. Frandsen, and CFO, Keith Alexander, at this investor event. To participate, please register on HC Andersen Capital’s website .   Certified Adviser Svensk Kapitalmarknadsgranskning AB Telefon: +46 11 32 30 732 E-post: ca@

Marcus Berglund New CEO of Pilotfish Networks

The Board of Directors of Pilotfish Networks AB , one of Europe’s leading providers of cloud-based system solutions for public transport, has appointed Marcus Berglund as the new CEO of the company. After a year of successful turnaround, the German principal owner, the global technology company Voith , and Pilotfish jointly decided the change in management to support the planned expansion of the company. Therefore, former Interim CEO Magnus Andersson is stepping down from day-to-day operations.Pilotfish has had a great opportunity during

Graduate’s passion for fashion is first-class

A graduate who swapped physics for fashion has styled a new career for herself after coming to Staffordshire Universitylizabeth Bishop began a degree in physics after her A Levels but quickly realised it wasn’t the right path for her and took the leap to follow her passion for fashion instead. She said: “Throughout the following years my interest in fashion developed past being a hobby. I proactively enrolled in a range of adult education classes. I learnt to sew, understand patterns and basic garment construction. I fell in love with the whole process, from choosing fabrics to wearing

Husqvarna Group appoints Erik Winberg as SVP Strategy & Innovation and new member of Group Management

Husqvarna Group today announced it has appointed Erik Winberg as Senior Vice President of the Strategy & Innovation (S&I) function, and as a new member of the Group Management team, effective from October 18, 2021.“I’m very pleased to welcome Erik to Husqvarna Group and to the management team. He has a strong track record and solid experience from strategic planning and digital transformation. Erik and the S&I team will play a central role in further positioning Husqvarna Group for future growth,” says Henric Andersson, President and CEO. The S&I function was formed in 2020 to accelerate

Jonas Larsson appointed as Head of Sitowise’s Swedish Operations and member of the Group Management team

Sitowise Group Plc                                                  Stock Exchange Release                                       18 August 2021 at 1 p.m. Jonas Larsson appointed as Head of Sitowise’s Swedish Operations and member of the Group Management teamJonas Larsson has been appointed as Head of Sitowise’s Swedish operations and member of the Group Management Team. Larsson will be responsible for the Sitowise’s business operations in Sweden and its comprehensive development. Jonas Larsson comes from the position as a VP in AFRY, where he has been responsible of the Connected

Mia Engnes proposed as new member of Swedish Stirling’s Board of Directors

The Nomination Committee of Swedish Stirling AB (publ) proposes that Mia Engnes – Director of Northvolt Ett – be elected to the company’s Board of Directors by an Extraordinary General Meeting. This is to strengthen the Board of Directors’ production expertise ahead of the autumn ramp-up of production volumes of the PWR BLOK.Clean-tech company Swedish Stirling’s Nomination Committee proposes that Mia Engnes – Director and Manager in charge of the construction of Northvolt’s battery plant in Skellefteå, Sweden – be elected as a Board Member at an Extraordinary General Meeting to be held on 6

Notice of Extraordinary General Meeting in Swedish Stirling AB (publ)

The shareholders of Swedish Stirling AB (publ), Reg. No 556760-6602, are hereby invited to the Extraordinary General Meeting on Monday, 6 September 2021.Information about measures due to the ongoing corona pandemicIn the light of the ongoing corona pandemic and in order to minimize any risk of spreading of the corona virus, the Board of Directors has decided that the Extraordinary General Meeting (the “EGM”) is to be held only through postal voting in accordance with temporary legislation. This means that the EGM will be conducted without the physical presence of shareholders,

First day of trading in Ectin Research

Today is the first day of trading in Ectin Research, a pharmaceutical company that specializes in research and development of drug candidates, primarily for bladder cancer.Ectin Research was founded in 2013 and is active in biotechnology. The company specializes in the research and development of drug candidates. The research is focused on developing drugs that aim to eliminate cancerous tumors in patients, with the greatest focus on the treatment of bladder cancer. In addition, the company intends to develop drugs for the treatment of breast, colorectal, and prostate cancer cells. “We

Swedish Stirling AB: Half year report 2021

Clean-tech company Swedish Stirling AB publishes its half year report for 2021 today.Swedish clean-tech company Swedish Stirling AB is publishing its interim report for the period 1 January 2021 – 30 June 2021 today. The full report is available for download on the company’s website. Material events during the second quarter include the following:  · Net sales for the period amounted to TSEK - (TSEK -). Total operating income for the quarter was TSEK 16,484 (TSEK 11,876). Earnings per share, before dilution, for the quarter was SEK -0.13 (SEK -0.18). · Swedish Stirling AB and

Arbitral tribunal appointed for the arbitration proceedings concerning the redemption of the minority shares in Tikkurila Oyj

Tikkurila OyjStock exchange releaseAugust 18, 2021 at 12.10 p.m. EEST As previously announced, PPG Finland Oy has on 11 June 2021 commenced mandatory redemption proceedings in respect of Tikkurila Oyj’s (“Tikkurila” or the “Company”) minority shares by applying for arbitration proceedings to be initiated in accordance with Chapter 18, Section 4 of the Finnish Companies Act in order to obtain ownership of all the issued and outstanding shares in Tikkurila. The Company has today been informed that the Redemption Board of the Finland Chamber of Commerce has appointed an arbitral

Selvaag Bolig ASA: Key information relating to the cash dividend to be paid

Dividend amount: 2.00 per shareDeclared currency: NOKLast day including right: 20 August 2021Ex-date: 23 August 2021Record date: 24 August 2021Payment date: 31 August 2021Date of approval: 17 August 2021  Further information from:Sverre Molvik, CEO, Selvaag Bolig ASATelephone: +47 40 10 05 85, e-mail: smo@selvaagbolig.no Kristoffer Gregersen, executive vice president communications and strategy, Selvaag Bolig ASATelephone: +47 95 77 55 93, e-mail: kgr@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer controlling the entire value chain

Publication of Orthex’s H1 Half Year Financial Report on August 25, 2021 and invitation to the result presentation on the same day

Orthex Corporation, Press release, August 18, 2021 at 12.00 p.m. EEST   Orthex will publish its Half Year Financial Report for the period of January−June 2021 on Wednesday, August 25, 2021 at around 09:00 a.m. EEST. Orthex’s CEO Alexander Rosenlew and CFO Saara Mäkelä will present the Interim Report on the same day at 11:00 a.m. EEST in a webcast. The webcast can be joined through this link.  The webcast presentation will be held in English. Q&AQuestions to the management can be sent through the meeting chat.

Cinclus Pharma announces the first patient randomized in the Phase II study for X842 in GERD.

Stockholm, Sweden: Cinclus Pharma Holding AB (“Cinclus Pharma”), a biopharmaceutical company focused on the development of a novel treatment for severe gastroesophageal reflux disease (“GERD”), today announced that the first patient has been randomized in the Phase II dose ranging study for its lead candidate drug X842.This is a randomized double-blind, double dummy, active comparator-controlled dose-finding study. The study will be conducted in the USA and in seven countries in Europe at approximately 60 sites. The primary objective of the study is to support dose selection of X842, for

Visma acquires Vuealta Oy and strengthens its expertise in business planning and analytics solutions

Visma Consulting Oy has acquired Vuealta Oy, Finland's leading provider of consultancy services in design and analytics solutions from Anaplan. Vuealta Oy was founded in 2016 and currently has a market share of more than 80 percent of Finland's Anaplan implementations. Visma Consulting is a strong player in the knowledge management consulting and software market, and the acquisition will strengthen this position. Vuealta will join Visma Consulting, which provides digitalisation services to Finnish companies and the public sector with about 500 experts. “I am very pleased that Vuealta

Half-Year Report 1 January 2021 – 30 June 2021

Growth continues to be strong supporting the full year guidance Risk Intelligence A/S (“Risk Intelligence” or "Company") hereby publishes the Half-year Report for the period January - June 2021. The report is available on the Company's Investor website.Highlights · A very strong quarter with continuing growth · Full year guidance for 2021 intact · Revenue Q2 increased by 58% · EBITDA 1H increased by 32% · Net profit 1H increased by 21% · Total revenue in 1H increased by 29% · Total ARR growth of 24% · Renewal rate Q2 of 100% (churn 0%) · 2-year extension

There are no items matching the current filter
There are no more items matching the current filter
Back to top